揚帆新材(300637.SZ):“29000t/a光引發劑、醫藥中間體項目”已具備正式生產條件
格隆匯5月20日丨揚帆新材(300637.SZ)公佈,公司全資子公司內蒙古揚帆新材料有限公司(“內蒙古揚帆”)近日向政府主管部門申請,組織有關專家和單位,對“29000t/a光引發劑、醫藥中間體項目”安全設施竣工驗收進行了審查,內蒙古揚帆按專家組的意見完成現場問題整改,並委託第三方評價機構修改完善了《安全設施竣工驗收評價報吿》。目前,項目竣工驗收整改已獲得專家組簽字確認並取得由內蒙古自治區應急管理廳頒發的安全生產許可證。
許可範圍:苯硫酚、三氯化鋁、鹽酸、1-氯丁烷、次氯酸鈉、硝酸鈉、亞磷酸、三氯氧磷
該安全生產許可證的取得,標誌着公司“29000t/a光引發劑、醫藥中間體項目”的各項工程、設備均已具備正式生產條件。在未來較長一段時間內,公司將基於下游市場的需求情況以及公司的整體市場戰略,合理安排各產品及生產線逐步、有序地生產放量。該項目全部投產後將會大幅的擴大公司產能,豐富公司產品的品類,往上游延伸形成的產業鏈將有利於公司控制成本,提高公司產品的市場競爭力和影響力。但因該項目達到滿負荷生產及市場消化還需要一定的週期,敬請投資者理性投資,注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.